Journey of remdesivir from the inhibition of hepatitis C virus to the treatment of COVID-19
If a planned path reaches a dead-end, one can simply stop. Or one can turn around, walk back to the last intersection and take another path, or one can consider taking few paths in parallel. The last scenario is reflective of the journey of remdesivir, the first antiviral for the treatment of COVID-...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publishing
2022-04-01
|
| Col·lecció: | Antiviral Therapy |
| Accés en línia: | https://doi.org/10.1177/13596535221082773 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|